Literature DB >> 26763667

Spontaneous Formation of Extensive Vessel-Like Structures in Murine Engineered Heart Tissue.

Andrea Stoehr1,2, Marc N Hirt1,2, Arne Hansen1,2, Moritz Seiffert1,2,3, Lenard Conradi1,2,3, June Uebeler1,2, Florian P Limbourg4, Thomas Eschenhagen1,2.   

Abstract

Engineered heart tissue (EHT) from primary heart cells contains endothelial cells (ECs), but the extent to which ECs organize into vessel-like structures or even functional vessels remains unknown and is difficult to study by conventional methods. In this study, we generated fibrin-based mini-EHTs from a transgenic mouse line (Cdh5-CreERT2 × Rosa26-LacZ), in which ECs were specifically and inducibly labeled by applying tamoxifen (EC(iLacZ)). EHTs were generated from an unpurified cell mix of newborn mouse hearts and were cultured under standard serum-containing conditions. Cre expression in 15-day-old EHTs was induced by addition of o-hydroxytamoxifen to the culture medium for 48 h, and ECs were visualized by X-gal staining. EC(iLacZ) EHTs showed a dense X-gal-positive vessel-like network with distinct tubular structures. Immunofluorescence revealed that ECs were mainly associated with cardiomyocytes within the EHT. EC(iLacZ) EHT developed spontaneous and regular contractility with forces up to 0.1 mN. Coherent contractility and the presence of an extensive vessel-like network were both dependent on the presence of animal sera in the culture medium. Contractile EC(iLacZ) EHTs successfully served as grafts in implantation studies onto the hearts of immunodeficient mice. Four weeks after implantation, EHTs showed X-gal-positive lumen-forming vessel structures connected to the host myocardium circulation as they contained erythrocytes on a regular basis. Taken together, genetic labeling of ECs revealed the extensive formation of vessel-like structures in EHTs in vitro. The EC(iLacZ) EHT model could help simultaneously study biological effects of compounds on cardiomyocyte function and tissue vascularization.

Entities:  

Mesh:

Year:  2016        PMID: 26763667      PMCID: PMC4799701          DOI: 10.1089/ten.TEA.2015.0242

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  36 in total

1.  Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21.

Authors:  M A Lawlor; P Rotwein
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 2.  Myofibroblasts and mechano-regulation of connective tissue remodelling.

Authors:  James J Tomasek; Giulio Gabbiani; Boris Hinz; Christine Chaponnier; Robert A Brown
Journal:  Nat Rev Mol Cell Biol       Date:  2002-05       Impact factor: 94.444

3.  Tissue engineering of a differentiated cardiac muscle construct.

Authors:  W-H Zimmermann; K Schneiderbanger; P Schubert; M Didié; F Münzel; J F Heubach; S Kostin; W L Neuhuber; T Eschenhagen
Journal:  Circ Res       Date:  2002-02-08       Impact factor: 17.367

4.  Cardiac grafting of engineered heart tissue in syngenic rats.

Authors:  Wolfram-Hubertus Zimmermann; Michael Didié; Gerald H Wasmeier; Uwe Nixdorff; Andreas Hess; Ivan Melnychenko; Oliver Boy; Winfried L Neuhuber; Michael Weyand; Thomas Eschenhagen
Journal:  Circulation       Date:  2002-09-24       Impact factor: 29.690

5.  Apoptosis in vascular endothelial cells caused by serum deprivation, oxidative stress and transforming growth factor-beta.

Authors:  N Hogg; J Browning; T Howard; C Winterford; D Fitzpatrick; G Gobé
Journal:  Endothelium       Date:  1999

6.  3D engineered heart tissue for replacement therapy.

Authors:  Thomas Eschenhagen; Michael Didié; Felix Münzel; Pia Schubert; Karin Schneiderbanger; Wolfram-Hubertus Zimmermann
Journal:  Basic Res Cardiol       Date:  2002       Impact factor: 17.165

7.  Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces.

Authors:  Tatsuya Shimizu; Masayuki Yamato; Yuki Isoi; Takumitsu Akutsu; Takeshi Setomaru; Kazuhiko Abe; Akihiko Kikuchi; Mitsuo Umezu; Teruo Okano
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

Review 8.  Regulation of cell size and contractile function by AKT in cardiomyocytes.

Authors:  Michael V G Latronico; Stefan Costinean; Maria Luisa Lavitrano; Cesare Peschle; Gianluigi Condorelli
Journal:  Ann N Y Acad Sci       Date:  2004-05       Impact factor: 5.691

Review 9.  Cardiac tissue engineering for replacement therapy.

Authors:  Wolfram-Hubertus Zimmermann; Thomas Eschenhagen
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

10.  Functional microRNA library screening identifies the hypoxamir miR-24 as a potent regulator of smooth muscle cell proliferation and vascularization.

Authors:  Jan Fiedler; Andrea Stöhr; Shashi Kumar Gupta; Dorothee Hartmann; Angelika Holzmann; Annette Just; Arne Hansen; Denise Hilfiker-Kleiner; Thomas Eschenhagen; Thomas Thum
Journal:  Antioxid Redox Signal       Date:  2013-11-19       Impact factor: 8.401

View more
  6 in total

1.  Inspiration from heart development: Biomimetic development of functional human cardiac organoids.

Authors:  Dylan J Richards; Robert C Coyle; Yu Tan; Jia Jia; Kerri Wong; Katelynn Toomer; Donald R Menick; Ying Mei
Journal:  Biomaterials       Date:  2017-07-12       Impact factor: 12.479

Review 2.  Extracellular Vesicles in Cardiac Regeneration: Potential Applications for Tissues-on-a-Chip.

Authors:  Karl T Wagner; Trevor R Nash; Bohao Liu; Gordana Vunjak-Novakovic; Milica Radisic
Journal:  Trends Biotechnol       Date:  2020-09-19       Impact factor: 21.942

3.  Thymosin β4 Improves Differentiation and Vascularization of EHTs.

Authors:  Tilman Ziegler; Rabea Hinkel; Andrea Stöhr; Thomas Eschenhagen; Karl-Ludwig Laugwitz; Ferdinand le Noble; Robert David; Arne Hansen; Christian Kupatt
Journal:  Stem Cells Int       Date:  2017-01-16       Impact factor: 5.443

4.  Bioengineering adult human heart tissue: How close are we?

Authors:  Richard J Mills; James E Hudson
Journal:  APL Bioeng       Date:  2019-03-14

Review 5.  Engineering tissue-specific blood vessels.

Authors:  Lauren A Herron; Corey S Hansen; Hasan E Abaci
Journal:  Bioeng Transl Med       Date:  2019-07-02

Review 6.  Multi-cellularity in cardiac tissue engineering, how close are we to native heart tissue?

Authors:  Thomas J Owen; Sian E Harding
Journal:  J Muscle Res Cell Motil       Date:  2019-06-20       Impact factor: 2.698

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.